Abstract-Anglotensm II (Ang II) appears to exert its contractile and growth-promotmg effects through the AT, receptor subtype, whereas the AT, subtype may have growth-mhlbltory and proapoptotlc properties Recently, some data have challenged this emerging concept To clan@ the role of AT, and AT2 receptors, we treated Wlstar rats that were infused with Ang II (120 rig/kg/mm subcutaneously by osmotic mmlpump), with the AT, antagonist losartan (10 mg/kg/d m the drmkmg water) and the AT, antagonist PD123319
A ng II, the final memator of the rerun-angotensm system, plays a pivotal physlolog& role m cardiovascular homeostasls It 1s a potent vasoconstnctor of the peripheral vasculature and induces growth of smooth muscle cells of blood vessels and m the heart ' Because of these actions, Ang II may play an important pathophyslologcal role m the development and maintenance of hypertension * Cellular responses to Ang II are mehated by specific cell membrane receptors Two mam subtypes of angotensm receptors have been pharmacologcally defined and cloned AT, receptors, whch are blocked spenficaliy by losartan, and AT, receptors, which are blocked specifically by PD123319 3*4 Ang II appears to exert its contractile and growth-promotmg effects through the ATI receptor subtype: 4 whereas the AT2 subtype has been suggested to have growth-mhlhtory and proapoptotlc properDes 56 Recently, some data have challenged this emergmg concept In two successwe pubhcahons,'* investigators obtamed results suggestmg that when Ang II was lnf&ed subcutaneously for 3 weeks into Wlstar rats, the increase m blood pressure that occurs in this expenmental paradqqn 1s medated by AT, receptors, as shown by abrogation of this effect by concurrent admmlstrahon of losartan, an AT, angotensm antagomst In contrast, me&al hypertrophy of aorta and coronary artenes was abohshed by concormtant adnumstratlon of the AT1 receptor antagomst PD123319 The Ang II-dependent growth of vascular smooth muscle cells was associated wth reversal to an munature phenotype, as shown by the expression of cellular fibronectm and nonmuscle myosm, which was abohshed when losartan was coadmunstered mth Ang II" In ad&non, admnustratlon of losartan alone to normal rats reproduced the Ang II-induced vascular hypertrophy The authors concluded that Ang II-mduced growth of vascular smooth muscle cells 1s mehated by AT, receptors, whereas the phenotyplc changes ofsmooth muscle cells are AT,-dependent a To clan@ the role of AT1 and AT2 receptors In Ang II-induced growth, we have reproduced m part the expenments reported previously' and have examined morphometntally small resistance size artenes m the coronary, renal, mesentenc, and femoral clrculatlon for evidence of growth m presence of AT, and AT2 receptor antagonism We treated Wlstar rats that were infused with Ang II (120 rig/kg/mm subcutaneously by osmotic mnupump), with the AT, antagonist losartan (10 mg/kg/d m the dnnkmg water) and/or the AT, antagonist PD123319 (30 mg/kg/d subcutaneously by osmonc mmlpump) for 21 days At the end of the study, 
Preparation of Small Arteries
Coronary, renal arcuate and femoral artenes were obtained as we have described previously ' "I The heart and the kidneys were placed m Ice-cold Krebs' solution The rat was then placed m the supme posmon, and the skm of the right hmd leg was mclsed An artery m the pophteal region about 2 mm m length was dissected To &sect coronary vessels, the nght ventricle was opened to expose coronary attenes m the mterventncular septum The mterventncular artery was followed to the cardiac apex, and then the chordae tendmae and the myocardmm were separated, and a 2-mm-long vessel was Isolated For the lrolatlon of renal cortical arteries, the renal capsule was first removed
The kidney was sectloned, and a renal artery was dlssected close to the renal cortex and then followed distally A renal arcuate artery about 2 mm m length was isolated Mesentenc small arteries were obtamed as previously described Supenor mesentenc arteries were taken from the part of the mesentenc vascular bed that feeds the JeJunum 8 to 10 cm distal to the pylorus A third-order branch 1 mm distant from the mtestme and about 2 mm m length was isolated The (Table 1 and Rg I), whereas blood pressure was unchanged m rats infused wth Ang II that received losartan Losartan alone had no effect on blood pressure Ang II-infused rats that received slmultaneously an mfuslon of PD123319 showed a rise m blood pressure similar to that of rats receiving only Ang II Body weight was slmllar m all rats except m Ang II-infused rats receiving losartan, m which It was lower (PC 05) than that of untreated rats (Table 1) The heart/body weight ratio and the cross-sectional area of the mtlma me&a of the aorta were mcreased (PC 05) by the Ang II mfuslon In losartan-treated rats infused with Ang II, the heart/body weight ratio was smaller (PC 05) and the cross-sectional area of the mtlma me&a of the aorta was lower (PC 05 by Student's t-test) than m Ang II-infused rats Interestingly, the cross-sectlonal area of aorta (corrected or not for body weight) of rats treated only with losartan or infused simultaneously with Ang II and mth the AT2 antagomst PD123319 achieved slmllar values, not slgmficantly different from those of either untreated or Ang II-infused rats but intermediate between these two groups. 
Weeks
Wire-myograph-mounted coronary, renal, mesentenc, and femoral small artenes had a greater media width, media cross-sectional area, and media/lumen ratio m Ang II-infused rats and m Ang II-infused rats receiving PD123319 than m untreated rats or Ang II-infused rats treated with losartan (Table 2 and Fig 2, PC 01) Losartan alone had no effect on small artery structure
Discussion
Besides Its vasoconstnctor role, Ang II acts as a growthpromotmg agent It induces growth (hypertrophy and/or hyperplasla) m many cultured cell types and m vlvo '2' "-" Like most of the known physlologcal effects of Ang II, evidence up to the present has suggested that these trophlc effects are mediated by AT, receptors Indeed, until recently, it was believed that vascular Ang II receptors were exclusively of the AT, subtype However, the adult rat aorta expresses a small but significant amount of AT2 receptors as well I4 In aorta of fetal and young rats, the proportion of AT2 receptors 1s higher, this predominance of AT, receptoe 1s reversed durmg develop- Sprague-Dawley rats, 81% of anglotencm receptors m the aorta are of the AT, subtype, m &week-old rats, this 1s reduced to 28%, with a predommance ofAT, (71%) l4 In 6-to g-week-old SHli and WKY rats, renal resistance vessels display 20% of Ang II bmdmg sites with affmlty to PD123319 " Recent studies have contributed to elucidate m part the elusive role of AT2 receptors Stoll et al" demonstrated an antlprohferatlve effect of Ang II on coronary endothehal cells, which could be blocked by the AT2 antagonist PD123177, and recent work has lmphcated AT, receptors m induction of apoptosls ' However, controversial studies have suggested a complex interaction of anglotensm receptor \ub-types m the regulation of growth Saward et al'" reported that PD123319 but not losartan could block Ang II-mduced KNA synthesis m Al0 vascular smooth muscle cells Finally, two recent studies m which Wlstar rats were treated for 3 weekc with Ang II and PD123319 showed that blood pre5Fure remained high but fibrosis and vascular hypertrophy were reduced by the AT, antagonist compared to Ang II mfuslon alone ' In contrast to the antlhypertrophlc effect of the AT? antagonist, reversal to an imature phenotype, as shown by expression of cellular fibronectm and nonmuscle myosm, which was associated with Ang II-dependent growth of vascular smooth muscle cells, was abolished when losartan was admmlstered with Ang II * Admmlstratron of losartan alone to normal rats reproduced the Ang II-induced vascular hypertrophy The authors concluded that Ang II-induced growth of vascular smooth muscle cells 1s mediated by ATI receptors, whereas the phenotyplc changes of smooth muscle cells are AT,-dependent * The present results, particularly the cardiac and the small artery data, are m contrast to the results of L&y et al' and Sabrl et al' and argue against the purported prohypertrophlc role of AT2 receptors They agree with previous evidence m favor of a role of AT, receptors m growth of vascular smooth muscle cells, leaving open the posslblhty of an antlprohferatlve and pro-apoptotlc action of AT2 receptors Cardiac weight and the volume per unit length (crosssectional area) of the mtlma media of the aorta were sign& cantly increased m angotensm II-infused rats only when evaluated relative to body weight, which was lower m this group Hypertensive rats very often exhibit lower body weight than normotenslve controls, and cardiac and vascular growth may not be apparent unless normalized by body weight However, Brmk et al" have reported that angotensm II mduces weight loss through a pressor-independent mechamsm that mvolves decreased food Intake and body fat Thts confounding factor has to be borne m mind, and the data regarding cardiac and aortlc growth should be evaluated m the perspective that decreased adiposity resulting from reduced food intake may have affected these tissues differently from other tissues In a previous study, we showed that m rats, aorta segment wet weight correlates with body weight*" and crosssectional area of aorta correlates with the weight of aorta segments but 1s a more precise measurement
The crosssectional area of the mtlma media of the aorta was lower m losartan-treated rats infused with Ang II than m Ang II-infused rats, achieving slgmficance (PC 05) only after a t-test but not by ANOVA Interestingly, the cross-sectional area of the aorta (corrected or not for body weight) of rats treated only with losartan or infused simultaneously with Ang II and with the AT, antagomst PD123319 achieved slmllar values (an Increase of 4% to 5% above control), which were not statlstlcally different from those m either untreated or Ang II-infused rats but were intermediate between these two groups This 1s somewhat similar to the report of aortlc growth m Ang II-infused rats by L&y et al ' and Sabn et al,' who found an increase of 5% m media thickness of aorta m Ang II-mfused rats receiving PD123319
and an increase of 10% m rats receiving only losartan The absence of statlstlcal slgmficance between some of these differences m mean values may be the result of a type II error, since the very limited amounts of the AT, antagonist available made it possible for only very small numbers of rats to be evaluated under treatment for 3 weeks With the large amounts of PD123319 required for a 3-weeklong treatment at the dose of this agent that had been employed m the previous studles,78 not enough was available to study a group receiving only PD123319 or a combuied group receiving losartan and PD123319 The potential exdlanation that AT2 receptors may play a modest growth-promotmg role in aorta, as suggested by L&y et al ' and Sabn et a1, 8 cannot be conclusively ruled out m the present study, especially consldenng other independent evidence showing the The mechamsm whereby angotensm II exerts its growthstlmulatmg effect via AT, receptors has been m part elucidated recently when some St&es have provided evidence that as m other tissues, m blood vessels Ang II smulates endothehn-1 production " 22 Rajagopalan et al*' demonstrated that after Ang II mtislon for 5 days m rats, endothelm expression m the deeper smooth muscle layerj of the aorta 1s enhanced, and blood pressure increase and aortlc growth are as well antagomzed by the AT1 antagomst losartan as by an ET,selechve endothehn receptor antagomst D'Usao et a12* showed that another ET, antagomst shghtly reduced blood pressure and abrogated growth of mesentent small artenes. Thus, smooth muscle expression of endothehn-1 appears to mediate m rats via ETA recepton the effects of exogenous angotensm II mf&lon, the latter stlmulatmg endothehn-1 through AT, receptor acnvatlon It 1s possible that this AT, receptor-mediated mvolvement of endothehn-1 m Ang IIinduced vascular growth m Ang II-mfised rats occurs mamly m response to exogenous Ang II, since m 24udney 1 chp Goldblatt hypertensive rats, a high remn (and therefore Ang II) hypertensive model, vascular growth 1s relatively mmor, wth eutrophc rather than hypertrophlc small artery remodelmg predommatmg," and endothelm-1 does not appear to play an important role 23 24 In this study, as m previous stumes exanumng small artery structure m the Ang II-mf&ed rat,'j hypertrophlc remodehng occurred w& no reduchon m lumen mameter of the resistance artenes exammed TUB remodelmg 1s smular to the one that has been attnbuted to endothelm,25 whereas m hypertensive models m which endothe- Figure   2 . The cross-secttonal area of media of small arteries dissected from the coronary, renal cortlcal, mesentenc, and femoral vasculature from Wrstar rats Infused or not Infused with anglotsnsn II (Ang II) and receivrng or not recervrng losartan or PD123329, studred on an Isometric wire-myograph 7% 01 versus control, losartan, or Ang II+ losartan hn 1s not involved but m which endogenous Ang II may play a role, the remodehng of small artenes 1s inward eutrophic, with reducnon of the lumen dameter, as found m 2-ladney 1 chp Goldblatt hypertensive rats23 and m spontaneously hypertensive rats 26
The absence of effects of the AT, antagonist m the present study could be due to meffectlve blockade of AT2 receptors by the dose of PD123319 used However, the dose used m the present study 1s a very large one, and it 1s that infused by LCvy et al' and Sabn et al' to postulate effects mediated by ATI receptors m thrs same expenmental paradigm It 1s not easy to demonstrate blockade of AT2 receptors unless bmdmg mhlbltlon with the pharmacological charactenstlcs of AT* receptor bmdmg 1s shown, since known physlologcal and blochenucal effects of AT2 receptors are presently mostly m vitro effects5'" with few documented m vlvo results " We are therefore unable m this study to certify that the dose that was used indeed achieved a blockade of putative ATI receptors to the same degree as m the previous studies,',* even if the dose used was the same, and this must be mentioned as a potential hmltatlon of the study The very large dose of PD123319 that had to be used m vlvo for 3 weeks and the very limited avallablhty of the compound precluded both the evaluation of larger numbers of rats m the PD123319-treated group and the mtroductlon of two expenmental groups that would be very useful for this study, that is, a group treated only with PD 123319 and one recelvmg Ang II, losartan, and PD123319 These are recognized hmltatlons of the study, since an appropriate baseline for comparison of the Ang II-infused PD123319-treated group 1s one receiving only PD123319 In conclusion, these results support the concept that m Wlstar normotenslve rats infused for 3 weeks with anglotensm II, growth m the heart, aorta, and coronary, renal, mesentenc, and femoral small artenes 1s mediated m large measure by the AT, receptor and show little evidence, particularly m heart and small mesentenc arteries, of a role of ATa receptors m mediating anglotensm II effects in this experimental paradigm
